Portfolio company
Nautilus Biotechnology
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops a single-molecule proteomics platform for pharmaceutical firms and academic researchers to quantify and analyse the human proteome.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
NAUT
This company develops a proteomic analysis platform to measure proteins for researchers, drug developers and diagnostic organisations.
Nplex Biosciences
This company develops high-throughput proteomics platforms for researchers in pharmaceutical and academic sectors to measure proteins for drug and biomarker discovery.
Olink Proteomics
This company develops protein biomarker analysis platforms and immunoassay panels for pharmaceutical firms and academic researchers to support drug discovery and disease research.
Proteomics
This company develops automated benchtop instruments for multiplexed protein analysis to assist researchers in the biotechnology and pharmaceutical industries.
Glyphic Bio
This company develops a single-molecule protein sequencing platform for researchers to identify amino acids and post-translational modifications in the human proteome.
Range Biotechnologies
This company develops a proteomics platform for high-throughput protein quantification to support pharmaceutical companies and clinical laboratories with drug discovery and diagnostics.
Zephyrus Biosciences
This company develops single-cell protein analysis instruments and research tools for academic, biopharmaceutical and clinical scientists conducting disease research.
Somalogic
This company provides proteomic analysis services and protein measurement platforms to academic medical centres, pharmaceutical companies and biotechnology organisations for life sciences research.
